Tech Company Inital Public Offerings

Lyra Therapeutics IPO

Lyra Therapeutics, based in Watertown, had an IPO event on 4/30/2020.

Transaction Overview

Company Name
Announced On
Transaction Type
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows: approximately $47.0 million to $50.0 million to fund the clinical development and manufacturing and other pre-commercialization expenses for LYR-210 through completion of our Phase 3 clinical trial; approximately $4.0 million to $6.0 million to fund the development of LYR-220 through completion of our Phase 2 clinical trial; and the remainder, if any, to complete the transfer of our manufacturing process to a contract manufacturer, for platform development and other research and development expenses for our pipeline, and for working capital and other general corporate purposes.

Company Information

Company Status
Mailing Address
480 Arsenal Way
Watertown, MA 02472
Email Address
Lyra Therapeutics (Nasdaq: LYRA) is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Our goal is to transform the ENT treatment paradigm by providing effective front-line solutions for physicians and new treatment options for their patients.
Lyra Therapeutics LinkedIn Company Profile
Social Media
Lyra Therapeutics Company Twitter Account
Company News
Lyra Therapeutics News
Lyra Therapeutics on Facebook
Lyra Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Maria Palasis
  Maria Palasis LinkedIn Profile  Maria Palasis Twitter Account  Maria Palasis News  Maria Palasis on Facebook
Chief Financial Officer
Donald Elsey
  Donald Elsey LinkedIn Profile  Donald Elsey Twitter Account  Donald Elsey News  Donald Elsey on Facebook
VP - Bus. Development
Corinne Noyes
  Corinne Noyes LinkedIn Profile  Corinne Noyes Twitter Account  Corinne Noyes News  Corinne Noyes on Facebook
VP - Operations
Laura Edgerly-Pflug
  Laura Edgerly-Pflug LinkedIn Profile  Laura Edgerly-Pflug Twitter Account  Laura Edgerly-Pflug News  Laura Edgerly-Pflug on Facebook
VP - R & D
Robert Richard
  Robert Richard LinkedIn Profile  Robert Richard Twitter Account  Robert Richard News  Robert Richard on Facebook
VP - Regulatory Affairs
Vineeta Belanger
  Vineeta Belanger LinkedIn Profile  Vineeta Belanger Twitter Account  Vineeta Belanger News  Vineeta Belanger on Facebook



Browse more venture capital transactions:

Prev: 4/29/2020: Avalyn Pharma venture capital transaction
Next: 4/30/2020: Topia venture capital transaction


Share this article


News on VC Transactions

We record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary